Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections
•Vancomycin-resistant enterococci (VRE) antibiotic options are limited.•Fosfomycin maintains good efficacy against VRE but clinical experience is limited. VRE susceptibility to chloramphenicol is ≥ 90%.•We tested the combination of chloramphenicol + fosfomycin (CAF+FOS) against 10 VRE strains from b...
Gespeichert in:
Veröffentlicht in: | Diagnostic microbiology and infectious disease 2021-02, Vol.99 (2), p.115241-115241, Article 115241 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 115241 |
---|---|
container_issue | 2 |
container_start_page | 115241 |
container_title | Diagnostic microbiology and infectious disease |
container_volume | 99 |
creator | Lagatolla, Cristina Milic, Johana Imperi, Francesco Cervoni, Matteo Bressan, Raffaela Luzzati, Roberto Di Bella, Stefano |
description | •Vancomycin-resistant enterococci (VRE) antibiotic options are limited.•Fosfomycin maintains good efficacy against VRE but clinical experience is limited. VRE susceptibility to chloramphenicol is ≥ 90%.•We tested the combination of chloramphenicol + fosfomycin (CAF+FOS) against 10 VRE strains from bloodstream infections.•CAF+FOS combination determined a synergic effect observed for 50% of the isolates and an additive effect for the remaining 50%.•The survival of G. mellonella larvae infected with a lethal dose of a VRE strain was significantly higher with antibiotic combination.
Vancomycin-resistant Enterococcus faecium (VREfm) infections are increasing. Current anti-VREfm options (linezolid and daptomycin) are suboptimal. Fosfomycin maintains good efficacy against VREfm and chloramphenicol is active against ≥ 90% of VREfm. We tested chloramphenicol + fosfomycin (CAF+FOS) against 10 VREfm isolated from blood. MICs were 64 to 512 µg/mL for fosfomycin and 8 to 16 µg/mL for chloramphenicol. The combination decreased both MICs, with a synergic effect in 50% of the isolates and an additive effect in the remaining 50%. Time-kill assays performed on fractional inhibitory concentration index ≤ 0.5 strains confirmed the synergism. The antibiotic combination at ¼ of minimum inhibitory concentrations (MICs) caused a ≥ 2 log10 reduction compared to the two antibiotics alone. Finally, we provided a proof of concept of the in vitro efficacy of CAF+FOS in G. mellonella. The survival of G. mellonella larvae treated with the combination was significantly higher. The activity of fosfomycin and chloramphenicol against VREfm increases when they are used in combination. |
doi_str_mv | 10.1016/j.diagmicrobio.2020.115241 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2456865297</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0732889320306180</els_id><sourcerecordid>2456865297</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-d3a9479cb8891d39a6cc554d6e344ec06c1b94586af570d01f7a96d265ceda423</originalsourceid><addsrcrecordid>eNqNkcluFDEQQC0EIkPgF5DFKRx68NYbN5QMixQJie1qucv2xKO2PdjukeZD-F8cdUAcOdWhXq0PoVeUbCmh3ZvDVju19w5SnFzcMsJqgrZM0EdoQ4d-bAjpyWO0IT1nzTCM_AI9y_lACGWjIE_RBeeUk5bwDfr19RxM2rtcHGAFxZ1cOeNosY3ZRn8GF7AKGsPdHJPyxzsTHMQZq71yIRd8UgFWrEkm1zYqFLwLxaQIEWDJ2CoDbvH46seXnfWvsctxVsXURIoeT3OMOpdklMcuWFM3iCE_R0-smrN58RAv0ff3u2_XH5vbzx8-Xb-7bUBwVhrN1Sj6EaZ6I9V8VB1A2wrdGS6EAdIBnUbRDp2ybU80obZXY6dZ14LRSjB-ia7WvscUfy4mF-ldBjPPKpi4ZMlE2w1dy8a-om9XtH4952SsPCbnVTpLSuS9FnmQ_2qR91rkqqUWv3yYs0ze6L-lfzxU4GYFTL325EySGZwJdU2X6k-kju5_5vwG6v2pkQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2456865297</pqid></control><display><type>article</type><title>Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Lagatolla, Cristina ; Milic, Johana ; Imperi, Francesco ; Cervoni, Matteo ; Bressan, Raffaela ; Luzzati, Roberto ; Di Bella, Stefano</creator><creatorcontrib>Lagatolla, Cristina ; Milic, Johana ; Imperi, Francesco ; Cervoni, Matteo ; Bressan, Raffaela ; Luzzati, Roberto ; Di Bella, Stefano</creatorcontrib><description>•Vancomycin-resistant enterococci (VRE) antibiotic options are limited.•Fosfomycin maintains good efficacy against VRE but clinical experience is limited. VRE susceptibility to chloramphenicol is ≥ 90%.•We tested the combination of chloramphenicol + fosfomycin (CAF+FOS) against 10 VRE strains from bloodstream infections.•CAF+FOS combination determined a synergic effect observed for 50% of the isolates and an additive effect for the remaining 50%.•The survival of G. mellonella larvae infected with a lethal dose of a VRE strain was significantly higher with antibiotic combination.
Vancomycin-resistant Enterococcus faecium (VREfm) infections are increasing. Current anti-VREfm options (linezolid and daptomycin) are suboptimal. Fosfomycin maintains good efficacy against VREfm and chloramphenicol is active against ≥ 90% of VREfm. We tested chloramphenicol + fosfomycin (CAF+FOS) against 10 VREfm isolated from blood. MICs were 64 to 512 µg/mL for fosfomycin and 8 to 16 µg/mL for chloramphenicol. The combination decreased both MICs, with a synergic effect in 50% of the isolates and an additive effect in the remaining 50%. Time-kill assays performed on fractional inhibitory concentration index ≤ 0.5 strains confirmed the synergism. The antibiotic combination at ¼ of minimum inhibitory concentrations (MICs) caused a ≥ 2 log10 reduction compared to the two antibiotics alone. Finally, we provided a proof of concept of the in vitro efficacy of CAF+FOS in G. mellonella. The survival of G. mellonella larvae treated with the combination was significantly higher. The activity of fosfomycin and chloramphenicol against VREfm increases when they are used in combination.</description><identifier>ISSN: 0732-8893</identifier><identifier>EISSN: 1879-0070</identifier><identifier>DOI: 10.1016/j.diagmicrobio.2020.115241</identifier><identifier>PMID: 33130503</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Chloramphenicol ; Fosfomycin ; Galleria mellonella ; Synergism ; VRE</subject><ispartof>Diagnostic microbiology and infectious disease, 2021-02, Vol.99 (2), p.115241-115241, Article 115241</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-d3a9479cb8891d39a6cc554d6e344ec06c1b94586af570d01f7a96d265ceda423</citedby><cites>FETCH-LOGICAL-c432t-d3a9479cb8891d39a6cc554d6e344ec06c1b94586af570d01f7a96d265ceda423</cites><orcidid>0000-0001-6121-7009</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.diagmicrobio.2020.115241$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33130503$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lagatolla, Cristina</creatorcontrib><creatorcontrib>Milic, Johana</creatorcontrib><creatorcontrib>Imperi, Francesco</creatorcontrib><creatorcontrib>Cervoni, Matteo</creatorcontrib><creatorcontrib>Bressan, Raffaela</creatorcontrib><creatorcontrib>Luzzati, Roberto</creatorcontrib><creatorcontrib>Di Bella, Stefano</creatorcontrib><title>Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections</title><title>Diagnostic microbiology and infectious disease</title><addtitle>Diagn Microbiol Infect Dis</addtitle><description>•Vancomycin-resistant enterococci (VRE) antibiotic options are limited.•Fosfomycin maintains good efficacy against VRE but clinical experience is limited. VRE susceptibility to chloramphenicol is ≥ 90%.•We tested the combination of chloramphenicol + fosfomycin (CAF+FOS) against 10 VRE strains from bloodstream infections.•CAF+FOS combination determined a synergic effect observed for 50% of the isolates and an additive effect for the remaining 50%.•The survival of G. mellonella larvae infected with a lethal dose of a VRE strain was significantly higher with antibiotic combination.
Vancomycin-resistant Enterococcus faecium (VREfm) infections are increasing. Current anti-VREfm options (linezolid and daptomycin) are suboptimal. Fosfomycin maintains good efficacy against VREfm and chloramphenicol is active against ≥ 90% of VREfm. We tested chloramphenicol + fosfomycin (CAF+FOS) against 10 VREfm isolated from blood. MICs were 64 to 512 µg/mL for fosfomycin and 8 to 16 µg/mL for chloramphenicol. The combination decreased both MICs, with a synergic effect in 50% of the isolates and an additive effect in the remaining 50%. Time-kill assays performed on fractional inhibitory concentration index ≤ 0.5 strains confirmed the synergism. The antibiotic combination at ¼ of minimum inhibitory concentrations (MICs) caused a ≥ 2 log10 reduction compared to the two antibiotics alone. Finally, we provided a proof of concept of the in vitro efficacy of CAF+FOS in G. mellonella. The survival of G. mellonella larvae treated with the combination was significantly higher. The activity of fosfomycin and chloramphenicol against VREfm increases when they are used in combination.</description><subject>Chloramphenicol</subject><subject>Fosfomycin</subject><subject>Galleria mellonella</subject><subject>Synergism</subject><subject>VRE</subject><issn>0732-8893</issn><issn>1879-0070</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqNkcluFDEQQC0EIkPgF5DFKRx68NYbN5QMixQJie1qucv2xKO2PdjukeZD-F8cdUAcOdWhXq0PoVeUbCmh3ZvDVju19w5SnFzcMsJqgrZM0EdoQ4d-bAjpyWO0IT1nzTCM_AI9y_lACGWjIE_RBeeUk5bwDfr19RxM2rtcHGAFxZ1cOeNosY3ZRn8GF7AKGsPdHJPyxzsTHMQZq71yIRd8UgFWrEkm1zYqFLwLxaQIEWDJ2CoDbvH46seXnfWvsctxVsXURIoeT3OMOpdklMcuWFM3iCE_R0-smrN58RAv0ff3u2_XH5vbzx8-Xb-7bUBwVhrN1Sj6EaZ6I9V8VB1A2wrdGS6EAdIBnUbRDp2ybU80obZXY6dZ14LRSjB-ia7WvscUfy4mF-ldBjPPKpi4ZMlE2w1dy8a-om9XtH4952SsPCbnVTpLSuS9FnmQ_2qR91rkqqUWv3yYs0ze6L-lfzxU4GYFTL325EySGZwJdU2X6k-kju5_5vwG6v2pkQ</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Lagatolla, Cristina</creator><creator>Milic, Johana</creator><creator>Imperi, Francesco</creator><creator>Cervoni, Matteo</creator><creator>Bressan, Raffaela</creator><creator>Luzzati, Roberto</creator><creator>Di Bella, Stefano</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6121-7009</orcidid></search><sort><creationdate>202102</creationdate><title>Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections</title><author>Lagatolla, Cristina ; Milic, Johana ; Imperi, Francesco ; Cervoni, Matteo ; Bressan, Raffaela ; Luzzati, Roberto ; Di Bella, Stefano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-d3a9479cb8891d39a6cc554d6e344ec06c1b94586af570d01f7a96d265ceda423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Chloramphenicol</topic><topic>Fosfomycin</topic><topic>Galleria mellonella</topic><topic>Synergism</topic><topic>VRE</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lagatolla, Cristina</creatorcontrib><creatorcontrib>Milic, Johana</creatorcontrib><creatorcontrib>Imperi, Francesco</creatorcontrib><creatorcontrib>Cervoni, Matteo</creatorcontrib><creatorcontrib>Bressan, Raffaela</creatorcontrib><creatorcontrib>Luzzati, Roberto</creatorcontrib><creatorcontrib>Di Bella, Stefano</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diagnostic microbiology and infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lagatolla, Cristina</au><au>Milic, Johana</au><au>Imperi, Francesco</au><au>Cervoni, Matteo</au><au>Bressan, Raffaela</au><au>Luzzati, Roberto</au><au>Di Bella, Stefano</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections</atitle><jtitle>Diagnostic microbiology and infectious disease</jtitle><addtitle>Diagn Microbiol Infect Dis</addtitle><date>2021-02</date><risdate>2021</risdate><volume>99</volume><issue>2</issue><spage>115241</spage><epage>115241</epage><pages>115241-115241</pages><artnum>115241</artnum><issn>0732-8893</issn><eissn>1879-0070</eissn><abstract>•Vancomycin-resistant enterococci (VRE) antibiotic options are limited.•Fosfomycin maintains good efficacy against VRE but clinical experience is limited. VRE susceptibility to chloramphenicol is ≥ 90%.•We tested the combination of chloramphenicol + fosfomycin (CAF+FOS) against 10 VRE strains from bloodstream infections.•CAF+FOS combination determined a synergic effect observed for 50% of the isolates and an additive effect for the remaining 50%.•The survival of G. mellonella larvae infected with a lethal dose of a VRE strain was significantly higher with antibiotic combination.
Vancomycin-resistant Enterococcus faecium (VREfm) infections are increasing. Current anti-VREfm options (linezolid and daptomycin) are suboptimal. Fosfomycin maintains good efficacy against VREfm and chloramphenicol is active against ≥ 90% of VREfm. We tested chloramphenicol + fosfomycin (CAF+FOS) against 10 VREfm isolated from blood. MICs were 64 to 512 µg/mL for fosfomycin and 8 to 16 µg/mL for chloramphenicol. The combination decreased both MICs, with a synergic effect in 50% of the isolates and an additive effect in the remaining 50%. Time-kill assays performed on fractional inhibitory concentration index ≤ 0.5 strains confirmed the synergism. The antibiotic combination at ¼ of minimum inhibitory concentrations (MICs) caused a ≥ 2 log10 reduction compared to the two antibiotics alone. Finally, we provided a proof of concept of the in vitro efficacy of CAF+FOS in G. mellonella. The survival of G. mellonella larvae treated with the combination was significantly higher. The activity of fosfomycin and chloramphenicol against VREfm increases when they are used in combination.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33130503</pmid><doi>10.1016/j.diagmicrobio.2020.115241</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-6121-7009</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0732-8893 |
ispartof | Diagnostic microbiology and infectious disease, 2021-02, Vol.99 (2), p.115241-115241, Article 115241 |
issn | 0732-8893 1879-0070 |
language | eng |
recordid | cdi_proquest_miscellaneous_2456865297 |
source | Elsevier ScienceDirect Journals Complete |
subjects | Chloramphenicol Fosfomycin Galleria mellonella Synergism VRE |
title | Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T03%3A55%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synergistic%20activity%20of%20fosfomycin%20and%20chloramphenicol%20against%20vancomycin-resistant%20Enterococcus%20faecium%20(VREfm)%20isolates%20from%20bloodstream%20infections&rft.jtitle=Diagnostic%20microbiology%20and%20infectious%20disease&rft.au=Lagatolla,%20Cristina&rft.date=2021-02&rft.volume=99&rft.issue=2&rft.spage=115241&rft.epage=115241&rft.pages=115241-115241&rft.artnum=115241&rft.issn=0732-8893&rft.eissn=1879-0070&rft_id=info:doi/10.1016/j.diagmicrobio.2020.115241&rft_dat=%3Cproquest_cross%3E2456865297%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2456865297&rft_id=info:pmid/33130503&rft_els_id=S0732889320306180&rfr_iscdi=true |